Elon Musk is taking on a new challenge, this time the U.S. federal budget. His goal? To cut $2 trillion from the $7 trillion ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

The startup plans to raise $400 Mn to $500 Mn through the public issue at a valuation of $1.5 Bn, sources told Inc42.

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Demand from investors covered all the shares offered by Hotelbeds owner HBX Group in its initial public offering within hours ...

Sebi is proposing a new combo product that pairs term life insurance with mutual fund investments, aiming to expand financial access and boost SIPs, particularly in rural areas.

Dr Agarwal's Healthcare will utilise ₹195 crore out of the net fresh issue proceeds for repaying its debt, and the remaining ...

Dr Agarwal's Health Care IPO received 1.55 times subscription on the final day, with QIBs showing strong interest. The Rs ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Demand from investors covered all the shares offered by Hotelbeds owner HBX Group in its initial public offering within hours ...

Captain Fresh, a B2B seafood startup, raised Rs 250 crore in pre-IPO funding, bolstering its financial base. With these funds, it aims to achieve USD 1 billion in revenue and bolster its market ...

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...